Innovative technology provides enhancement to advanced radiation therapy
Neutron Capture Enhanced Particle Therapy developed at ANSTO.
Showing 381 - 400 of 1197 results
Neutron Capture Enhanced Particle Therapy developed at ANSTO.
Australian-first detector to accelerate cancer research unveiled.
Favourable conceptual design review may lead to expanded role for Australia on ITER diagnostics.
ANSTO has collaborated on a study assessing the impact of the commonly-used food additive titanium dioxide (TiO2) on gut microbiota and inflammation.
When an energetic ion beam hits a sample it will interact with the atoms through a number of very complex interactions. By detecting and measuring the reaction products resulting from the various interactions and their intensities, you can obtain quantitative data on the sample's constituent elements and their spatial distribution.
ANSTO’s OPAL multi-purpose research reactor at Lucas Heights has officially returned to power and recommenced operations, following a months-long planned shutdown to carry out essential maintenance and upgrades.
Sample environments, Data analysis, SpICE and SICS
Sample environments, Data Analysis.
Environmental scientists at ANSTO have been undertaking research to gain a better understanding of the potential impact of contaminants on decommissioned offshore oil and gas infrastructure since 2017
ANSTO providing support to emergency services, closed to non-essential staff.
This afternoon, the Chair of ANSTO, Dr Annabelle Bennett, wrote to all staff to let them know that CEO Dr Adi Paterson has decided to resign. She said the Board is deeply appreciative of the contributions Adi has made, including to the health, research and academic outputs of ANSTO during his tenure. Mr Shaun Jenkinson will continue as Acting CEO, while the Board undertakes a global search for a permanent CEO.
ANSTO expert in molecular imaging contributed to international workshop.
Doping with transition metals produced stability in bismuth oxide.
The radiography program focuses on the development of Neutron Capture Enhanced Particle Therapy (NCEPT) from initial preclinical work, to clinical trials and finally commercial translation and licencing.